Abstract: A method for making an aliphatic diisocyanate by (a) phosgenating an aliphatic diamine in the presence of an inert solvent or gas to form a crude reaction mixture; (b) distilling the crude reaction mixture to form an aliphatic diisocyanate production stream and an aliphatic diisocyanate waste stream; (c) introducing the aliphatic diisocyanate waste stream to a chamber and placing the waste stream under supercritical fluid conditions sufficient to dissolve an appreciable amount of the aliphatic diisocyanate component in the supercritical fluid; (d) separating the dissolved aliphatic diisocyanate component from the waste stream, wherein the remaining waste stream is a supercritically-purged aliphatic diisocyanate waste stream; (e) lowering the pressure sufficiently to precipitate the aliphatic diisocyanate component.
Type:
Grant
Filed:
December 28, 1999
Date of Patent:
October 23, 2001
Assignee:
Bayer Corporation
Inventors:
Alexa B. Sommer, Mary Ann Wittig, Edwin Ray Hortelano, Philip E. Yeske, Jane F. Ciebien
Abstract: Novel aminediol compounds, pharmaceutical compositions containing these compounds, and methods of using these compounds in inhibiting retroviral protease, particularly useful in the treatment and/or prevention of HIV infection (AIDS).
Type:
Grant
Filed:
May 31, 1995
Date of Patent:
July 7, 1998
Assignee:
E. R. Squibb & Sons, Inc.
Inventors:
Eric M. Gordon, Joel C. Barrish, Gregory S. Bisacchi, Chong-Qing Sun, Joseph A. Tino, Gregory D. Vite, Robert Zahler